193 related articles for article (PubMed ID: 10825389)
21. Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma.
Capra V; Nicosia S; Ragnini D; Mezzetti M; Keppler D; Rovati GE
Mol Pharmacol; 1998 Apr; 53(4):750-8. PubMed ID: 9547367
[TBL] [Abstract][Full Text] [Related]
22. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
Maekawa A; Kanaoka Y; Lam BK; Austen KF
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
[TBL] [Abstract][Full Text] [Related]
23. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
[TBL] [Abstract][Full Text] [Related]
24. The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells.
Boehmler AM; Drost A; Jaggy L; Seitz G; Wiesner T; Denzlinger C; Kanz L; Möhle R
J Immunol; 2009 Jun; 182(11):6789-98. PubMed ID: 19454674
[TBL] [Abstract][Full Text] [Related]
25. Activation of CysLT receptors induces astrocyte proliferation and death after oxygen-glucose deprivation.
Huang XJ; Zhang WP; Li CT; Shi WZ; Fang SH; Lu YB; Chen Z; Wei EQ
Glia; 2008 Jan; 56(1):27-37. PubMed ID: 17910051
[TBL] [Abstract][Full Text] [Related]
26. Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
Chang BS; Chang JC; Wang YS; Huang SC
Neurogastroenterol Motil; 2008 Oct; 20(10):1140-6. PubMed ID: 18651869
[TBL] [Abstract][Full Text] [Related]
27. The ACh-induced contraction in rat aortas is mediated by the Cys Lt1 receptor via intracellular calcium mobilization in smooth muscle cells.
Mazzetti L; Franchi-Micheli S; Nistri S; Quattrone S; Simone R; Ciuffi M; Zilletti L; Failli P
Br J Pharmacol; 2003 Feb; 138(4):707-15. PubMed ID: 12598425
[TBL] [Abstract][Full Text] [Related]
28. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
29. Leukotriene-induced contraction is mediated by cysteinyl leukotriene receptor CysLT1 in guinea pig fundus but by CysLT1 and CysLT2 in antrum.
Huang SC
Life Sci; 2011 Apr; 88(17-18):819-24. PubMed ID: 21396378
[TBL] [Abstract][Full Text] [Related]
30. Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells.
Suzuki S; Takeuchi K; Ishinaga H; Basbaum C; Majima Y
Pharmacology; 2008; 81(3):221-8. PubMed ID: 18176092
[TBL] [Abstract][Full Text] [Related]
31. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
Bäck M; Jonsson EW; Dahlén SE
Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
33. A second cysteinyl leukotriene receptor in human lung.
Labat C; Ortiz JL; Norel X; Gorenne I; Verley J; Abram TS; Cuthbert NJ; Tudhope SR; Norman P; Gardiner P
J Pharmacol Exp Ther; 1992 Nov; 263(2):800-5. PubMed ID: 1331415
[TBL] [Abstract][Full Text] [Related]
34. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
[TBL] [Abstract][Full Text] [Related]
35. CysLT1 signal transduction in differentiated U937 cells involves the activation of the small GTP-binding protein Ras.
Capra V; Ravasi S; Accomazzo MR; Parenti M; Rovati GE
Biochem Pharmacol; 2004 Apr; 67(8):1569-77. PubMed ID: 15041474
[TBL] [Abstract][Full Text] [Related]
36. Agonist-induced desensitization/resensitization of human G protein-coupled receptor 17: a functional cross-talk between purinergic and cysteinyl-leukotriene ligands.
Daniele S; Trincavelli ML; Gabelloni P; Lecca D; Rosa P; Abbracchio MP; Martini C
J Pharmacol Exp Ther; 2011 Aug; 338(2):559-67. PubMed ID: 21531793
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S214-9. PubMed ID: 9620942
[TBL] [Abstract][Full Text] [Related]
38. Leukotriene D(4) enhances the function of endothelin-1-primed fibroblasts.
Tokuriki S; Ohshima Y; Yamada A; Ohta N; Tsukahara H; Mayumi M
Clin Immunol; 2007 Oct; 125(1):88-94. PubMed ID: 17627891
[TBL] [Abstract][Full Text] [Related]
39. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
[TBL] [Abstract][Full Text] [Related]
40. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].
Cai BL; Huang XQ; Dong XW; Fang SH; Lu YB; Zhang WP; Hu YZ; Shen JG; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 38(6):598-604. PubMed ID: 20014485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
